Engineers Gate Manager’s Fate Therapeutics FATE Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q1 | – | Sell |
-26,533
| Closed | -$43.8K | – | 2277 |
|
2024
Q4 | $43.8K | Buy |
+26,533
| New | +$43.8K | ﹤0.01% | 2103 |
|
2024
Q1 | – | Sell |
-46,847
| Closed | -$175K | – | 2026 |
|
2023
Q4 | $175K | Buy |
46,847
+31,460
| +204% | +$118K | 0.01% | 1672 |
|
2023
Q3 | $32.6K | Sell |
15,387
-23,193
| -60% | -$49.2K | ﹤0.01% | 1683 |
|
2023
Q2 | $184K | Buy |
+38,580
| New | +$184K | 0.01% | 1488 |
|
2023
Q1 | – | Sell |
-151,152
| Closed | -$1.53M | – | 1766 |
|
2022
Q4 | $1.53M | Buy |
151,152
+106,039
| +235% | +$1.07M | 0.09% | 278 |
|
2022
Q3 | $1.01M | Buy |
+45,113
| New | +$1.01M | 0.06% | 433 |
|
2022
Q2 | – | Sell |
-27,252
| Closed | -$1.06M | – | 2005 |
|
2022
Q1 | $1.06M | Buy |
+27,252
| New | +$1.06M | 0.04% | 623 |
|
2021
Q4 | – | Sell |
-20,482
| Closed | -$1.21M | – | 2090 |
|
2021
Q3 | $1.21M | Buy |
20,482
+5,008
| +32% | +$297K | 0.07% | 413 |
|
2021
Q2 | $1.34M | Buy |
15,474
+4,044
| +35% | +$351K | 0.09% | 312 |
|
2021
Q1 | $942K | Buy |
+11,430
| New | +$942K | 0.05% | 614 |
|
2020
Q4 | – | Sell |
-6,939
| Closed | -$277K | – | 1781 |
|
2020
Q3 | $277K | Sell |
6,939
-3,383
| -33% | -$135K | 0.01% | 1291 |
|
2020
Q2 | $354K | Buy |
+10,322
| New | +$354K | 0.02% | 1138 |
|
2019
Q4 | – | Sell |
-18,548
| Closed | -$288K | – | 1673 |
|
2019
Q3 | $288K | Buy |
18,548
+7,448
| +67% | +$116K | 0.01% | 1021 |
|
2019
Q2 | $225K | Buy |
+11,100
| New | +$225K | 0.01% | 952 |
|